Jennifer Drew

Since obtaining a BSc in Biochemistry from the University of Manchester, Jen has worked for over 20 years with antibody-based formats within GSK. Initially working on expression and purification of antibody-based molecules, then moving focus to biophysical analytical techniques including differential scanning calorimetry (DSC) and dynamic light scattering (DLS). Jen leads the team that developed and embedded the panel of in vitro Translational Developability assays to assess in vivo suitability of lead panels of antibody candidates within GSK.